Bringing the fundamentals into focus…
Back to Amphastar Pharmaceuticals, Inc.
How Amphastar Pharmaceuticals, Inc. stacks up
AMPH · against 422 other Healthcare companies of similar size
Growth
33/ 100
Below the middle of the pack.
Ranked #276 of 423 · scores higher than 35% of peers
Bars: peers in each 10-point band of the growth score36 peers with a growth score of 30–39, including AMPH · Click a bar to see the companies
Why growth scores 33?
Weighted metrics compared with all Healthcare companies.Mainly because of its earnings per share growth and revenue growth, which are weaker than most Healthcare peers.
- slower growth in earnings per share: weaker than 85% of peers. Earnings per share growth: -36.3% vs peer median 9.8%
- slower revenue growth over the last year: weaker than 67% of peers. Revenue growth: 1.0% vs peer median 6.1%
- faster revenue growth over three years: stronger than 63% of peers. 3-year revenue growth: 10.5% vs peer median 5.8%
Metric by metric
Position: dot = AMPH, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | AMPH | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 429 reported | 1.0% | 5.4% | 36% | 33% | |
| Earnings per share growthHigher is better · 237 reported | -36.3% | 7.3% | 15% | 33% | |
| 3-year revenue growthHigher is better · 416 reported | 10.5% | 6.2% | 62% | 33% |
Ranking by growth score
Top 5 and the companies ranked around AMPH| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 1 | 1.4B USD | 99 | 73 | |
| 1 | 2.1B USD | 99 | 96 | |
| 1 | 885M USD | 99 | 33 | |
| 1 | 609M USD | 99 | 91 | |
| 269 | 1.7B USD | 34 | 35 | |
| 269 | 775M USD | 34 | 31 | |
| 269 | 56.1B INR (≈$673M) | 34 | 49 | |
| 276 | 3.4B SAR (≈$909M) | 33 | 62 | |
| 276 | 1.2B USD | 33 | 52 | |
| 278 | 6.8B CNY (≈$947M) | 32 | 27 | |
| 278 | 838M USD | 32 | 33 | |
| 278 | 142.5B INR (≈$1.7B) | 32 | 71 | |
| 281 | 193.1B JPY (≈$1.3B) | 31 | 48 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score